Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Veronika Patcha Brodin"'
Autor:
Johanna Raffetseder, Elsje Pienaar, Robert Blomgran, Daniel Eklund, Veronika Patcha Brodin, Henrik Andersson, Amanda Welin, Maria Lerm
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112426 (2014)
The standard treatment of tuberculosis (TB) takes six to nine months to complete and this lengthy therapy contributes to the emergence of drug-resistant TB. TB is caused by Mycobacterium tuberculosis (Mtb) and the ability of this bacterium to switch
Externí odkaz:
https://doaj.org/article/e1ed0d292b25402183ce60375c818df8
Autor:
Robert Blomgran, Veronika Patcha Brodin, Deepti Verma, Ida Bergström, Peter Söderkvist, Christopher Sjöwall, Per Eriksson, Maria Lerm, Olle Stendahl, Eva Särndahl
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e31326 (2012)
Neutrophils are key-players in the innate host defense and their programmed cell death and removal are essential for efficient resolution of inflammation. These cells recognize a variety of pathogens, and the NOD-like receptors (NLRs) have been sugge
Externí odkaz:
https://doaj.org/article/f337bbdf644043a8b72cbdb5f8308cb3
Autor:
Eva Särndahl, Ida Bergström, Veronika Patcha Brodin, Johnny Nijm, Helen Lundqvist Setterud, Lena Jonasson
Publikováno v:
PLoS ONE, Vol 2, Iss 10, p e1056 (2007)
BACKGROUND: During the last years, neutrophils have emerged as important players in atherogenesis. They are highly activated in peripheral blood of patients with unstable angina. Moreover, a primed state of circulating neutrophils has been proposed i
Externí odkaz:
https://doaj.org/article/e8a2775f0d3648519b5a002db3e789f8
Autor:
Veronika Patcha Brodin, Gunnar Adell, Sebastian Gnosa, Hong Zhang, Xiao-Feng Sun, John Carstensen
Publikováno v:
British Journal of Cancer
BACKGROUND: Preoperative radiotherapy (RT) is widely used to downstage rectal tumours, but the rate of recurrence varies significantly. Therefore, new biomarkers are needed for better treatment and prognosis. It has been shown that astrocyte elevated
Autor:
Sofia Ramström, Torbjörn Bengtsson, J. Lönn, Ida Bergström, Emma Börgeson, Veronika Patcha Brodin, Fariba Nayeri, Eva Särndahl
Publikováno v:
Infection and Immunity. 79:1489-1497
Porphyromonas gingivalis is an etiological agent that is strongly associated with periodontal disease, and it correlates with numerous inflammatory disorders, such as cardiovascular disease. Circulating bacteria may contribute to atherogenesis by pro
Publikováno v:
The Journal of Immunology. 178:7357-7365
Phagocytosis is a complex process involving the activation of various signaling pathways, such as the Rho GTPases, and the subsequent reorganization of the actin cytoskeleton. In neutrophils, Rac and Cdc42 are activated during phagocytosis but less i
Autor:
Olle Stendahl, Veronika Patcha Brodin, Robert Blomgran, Deepti Verma, Eva Särndahl, Per Eriksson, Ida Bergström, Christopher Sjöwall, Maria Lerm, Peter Söderkvist
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 3, p e31326 (2012)
PLoS ONE, Vol 7, Iss 3, p e31326 (2012)
Background: Neutrophils are key-players in the innate host defense and their programmed cell death and removal are essential for efficient resolution of inflammation. These cells recognize a variety of pathogens, and the NOD-like receptors (NLRs) hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d874d185e6997b56f97d5ba6ecde6f2
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-77736
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-77736
Autor:
Veronika Patcha Brodin, Ida Bergström, Helen Lundqvist Setterud, Lena Jonasson, Johnny Nijm, Eva Särndahl
Publikováno v:
PLoS ONE, Vol 2, Iss 10, p e1056 (2007)
PLoS ONE
PLoS ONE
BACKGROUND: During the last years, neutrophils have emerged as important players in atherogenesis. They are highly activated in peripheral blood of patients with unstable angina. Moreover, a primed state of circulating neutrophils has been proposed i
Autor:
Gunnar Adell, Veronika Patcha Brodin, Ivana Tichá, Xiao-Feng Sun, Hong Zhang, Gunnar Arbman, Sebastian Gnosa
Publikováno v:
Cancer Research. 74:4897-4897
Background: Colorectal cancer (CRC) is the third most common cancer in men and the second in woman worldwide. The therapy of CRC has been critically improved during the past two decades, but the treatment response varies significantly between differe